Little Green Pharma
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 10 Feb 2025
- Reported shorts
- 961
- Shares on issue
- 302.873M
Little Green Pharma (LGP) Short Interest
Little Green Pharma (ASX:LGP) had 0.00% of shares reported as short positions as of 10 Feb 2025, representing 961 shares. Little Green Pharma operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Little Green Pharma
Little Green Pharma is an Australian company focused on the cultivation and production of medicinal cannabis products. They aim to provide pharmaceutical-grade cannabis for various medical applications, positioning themselves within the growing medicinal cannabis market.
Company profile →Little Green Pharma (ASX:LGP) has 0.00% of its shares on issue reported as short positions as of 10 Feb 2025, or about 961 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.26% in February 2021. LGP is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads LGP today
- Zanger BreakoutWatchScore 16rank 1471 of 1942
- CAN SLIMNot a candidate
- Minervini Trend TemplateNot a candidate
- Crowded-Short BreakoutNot a candidate
- Quality compoundersWatchScore 23rank 633 of 1669
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
LGP fundamentals
In the year to 31 Mar 2026, Little Green Pharma (ASX:LGP) recorded revenue of A$42.4M and a net loss after tax of A$1.4M. A year earlier it recorded revenue of A$36.8M and net profit after tax of A$3.3M. Year-on-year growth: revenue +15.2% (FY). Net margin −3.3%, return on equity −1.7% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest LGP news
All news- Why Trump’s diesel deal offers little relief from the oil squeeze
afr · 12 Oct 2026
- Earn Only a Little From Work? Will You Get the Full New Standard Deduction?
kalkine · 5 Oct 2026
- Could TGA Closed-Loop Reforms Hit Little Green Pharma (ASX:LGP)? - Kalkine Media
googlenews · 5 Oct 2026
Company details
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss LGP
Start a research thread or post the first pulse update